Lincoln Pharma Share Price

Lincoln Pharma (INR)914.3151.1   (19.8%)

Exchange ScripsBSE531633NSELINCOLNISININE405C01035

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Lincoln Pharma Performance

Market performance
Open price784
High915.8
Volumes3266397
Prev Close914.3
Low773.85
Closing date2024-12-04
Historical performance
1 Year High915.80
3 Year High915.80
5 Year High915.80
1 Year Low534.80
3 Year Low255.00
5 Year Low85.05

Lincoln Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1525
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
16.38
Dividend Yield
Dividend Yield
0.02 %

Lincoln Pharma Investment Returns

1 Year
12.6%
3 Years
115.5%
5 Years
356.3%
10 Years
N/A

Lincoln Pharma Technicals

IndicatorsValueSignal
5-DMA716.37Bullish
10-DMA669.5Bullish
20-DMA659.92Bullish
50-DMA668.12Bullish
100-DMA679.78Bullish
200-DMA646.16Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters2525252526
Foreign Investors---------------
Domestic Investors2525252526
Public Investors3130529942313502929128644
Government---------------

Lincoln Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income34422510057
Operating Profit134311171055928
Interest15201516
Depreciation106928176
Profit Before Tax12221005959837
Consolidated Net Profit933729694623
Adjusted EPS47363531

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital200200200200
Total Reserves5728482441283464
Minority Interest------------
Total Non-Current Liabilities152380110261
Total Liabilities7254636555464873
Capital Work in Progress356716117
Total Assets7254636555464873

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities632393761693
Cash Flow from Investing Activities-573-366-781-642
Cash Flow from Financing Activitie-52-45-26-57
Net Cash Inflow / Outflow7-19-45-7
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 16.38.
  • 3Y Stock Price CAGR of the stock is 29.2.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹1343 Million.
  • The company generated revenue of ₹5805 Million in the previous financial year.

Lincoln Pharma

914.3151.1   (19.8%)

Investment Amount: ₹ 66985
Current Value: ₹ 91430
Performence: 36.5%
P/L: ₹ 24445
Top Gainers
SymbolChange%
JINDWORLD387.35(20%)
MCL63.84(20%)
BANG66.64(20%)
LINCOLN763.2(20%)
BSL285.77(19%)
Top Losers
SymbolChange%
PAR278.8(-20%)
GRANULES534.15(-10%)
AKI16.11(-10%)
MAPMYINDIA1538.1(-9%)
MALUPAPER48.24(-9%)
INDGN626.85(-6%)
STARPAPER227.82(-6%)
ZENTEC1806.4(-6%)
Similar stocks

Vimta Labs

61.3

923.85

November 4 - December 4

Innova Captab

38.8

1093.4

November 4 - December 4

Krebs Biochem.&Inds

31.4

106.58

November 4 - December 4

Jagsonpal Pharma

29.9

714.1

November 4 - December 4

Bliss GVS Pharma

29

163.84

November 4 - December 4

Panacea Biotec

28.3

446.3

November 4 - December 4

Dishman Carbogen Amc

27.7

246.72

November 4 - December 4

Supriya Lifescience

24.8

796.35

November 4 - December 4

Announcing Stock of the Month!

Stock of the Month
Stock of the Month